Tower Research Capital (TRC)’s Mineralys Therapeutics MLYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $37.2K | Buy |
2,749
+1,575
| +134% | +$21.3K | ﹤0.01% | 3226 |
|
|
2025
Q1 | $18.6K | Buy |
1,174
+169
| +17% | +$2.68K | ﹤0.01% | 3042 |
|
|
2024
Q4 | $12.4K | Sell |
1,005
-1,669
| -62% | -$20.5K | ﹤0.01% | 3621 |
|
|
2024
Q3 | $32.4K | Sell |
2,674
-697
| -21% | -$8.44K | ﹤0.01% | 2961 |
|
|
2024
Q2 | $39.4K | Buy |
3,371
+3,076
| +1,043% | +$36K | ﹤0.01% | 3278 |
|
|
2024
Q1 | $3.81K | Sell |
295
-2,584
| -90% | -$33.4K | ﹤0.01% | 4787 |
|
|
2023
Q4 | $24.8K | Sell |
2,879
-7,181
| -71% | -$61.8K | ﹤0.01% | 3527 |
|
|
2023
Q3 | $95.7K | Buy |
10,060
+9,718
| +2,842% | +$92.4K | ﹤0.01% | 2010 |
|
|
2023
Q2 | $5.83K | Sell |
342
-1,156
| -77% | -$19.7K | ﹤0.01% | 4760 |
|
|
2023
Q1 | $23K | Buy |
+1,498
| New | +$23K | ﹤0.01% | 3289 |
|